Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-26 @ 12:27 AM
Study NCT ID:
NCT03443960
Status:
COMPLETED
Last Update Posted:
2018-04-24
First Post:
2018-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules
Sponsor:
Tonix Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-29
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-09
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-06
First Submit QC Date:
None
Study First Post Date:
2018-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-23
Last Update Post Date:
2018-04-24
Last Update Post Date Type:
ACTUAL